<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To study the clinical overlap between <z:e sem="disease" ids="C0035372" disease_type="Disease or Syndrome" abbrv="RTT">Rett</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RTT</z:e>) and <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndromes (AS)</z:e>, we screened the MECP2 gene in a cohort of 78 patients diagnosed as possible AS but who showed a <z:mpath ids='MPATH_458'>normal</z:mpath> methylation pattern at the UBE3A locus </plain></SENT>
<SENT sid="1" pm="."><plain>MECP2 missense (R106W, G428S), nonsense (R255X, R270X), and frameshift mutations (803 delG) were identified in 6/78 patients including 4/6 female cases consistent with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RTT</z:e>, one female case with <z:hpo ids='HP_0002448'>progressive encephalopathy</z:hpo> of <z:hpo ids='HP_0003623'>neonatal onset</z:hpo>, and one isolated male case with non-fatal, non-<z:hpo ids='HP_0002448'>progressive encephalopathy</z:hpo> of <z:hpo ids='HP_0003623'>neonatal onset</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This study shows that MECP2 mutations can account for a broad spectrum of clinical presentations and raises the difficult issue of the screening of the MECP2 gene in severe <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> in both males and females </plain></SENT>
</text></document>